Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Artiva Biotherapeutics (ARTV) Institutional Ownership

Artiva Biotherapeutics logo
$8.78 -0.44 (-4.74%)
As of 12:44 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Artiva Biotherapeutics (NASDAQ:ARTV)

Number of
Institutional Buyers
(last 12 months)
16
Total
Institutional Inflows
(last 12 months)
$3.90M
Number of
Institutional Sellers
(last 12 months)
8
Total
Institutional Outflows
(last 12 months)
$4.30M
Get ARTV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Artiva Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ARTV Institutional Buying and Selling by Quarter

Artiva Biotherapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2026 venBio Partners LLC531,337$3.42M1.2%-18.1%2.149%
5/15/2026 OMERS ADMINISTRATION Corp11,400$73K0.0%-46.0%0.046%
5/14/2026 Renaissance Technologies LLC80,038$515K0.0%-31.1%0.324%
5/7/2026 Dimensional Fund Advisors LP20,370$131K0.0%N/A0.082%
5/5/2026 Sanctuary Advisors LLC21,581$139K0.0%N/A0.087%
4/27/2026 Simplify Asset Management Inc.23,230$150K0.0%N/A0.094%
2/18/2026 venBio Partners LLC648,507$2.78M1.3%-43.6%2.642%
2/18/2026 Millennium Management LLC217,097$931K0.0%-17.2%0.884%
2/16/2026 OMERS ADMINISTRATION Corp21,100$91K0.0%N/A0.086%
2/13/2026 Marshall Wace LLP79,559$341K0.0%N/A0.324%
2/13/2026 State Street Corp35,824$154K0.0%-40.1%0.146%
2/12/2026 Jane Street Group LLC40,671$174K0.0%N/A0.166%
2/12/2026 Renaissance Technologies LLC116,200$498K0.0%+46.8%0.473%
2/10/2026 Goldman Sachs Group Inc.12,060$52K0.0%-75.8%0.049%
2/9/2026 Geode Capital Management LLC101,117$434K0.0%-8.8%0.412%
11/17/2025 Qube Research & Technologies Ltd25,552$73K0.0%-34.0%0.104%
11/17/2025 Prelude Capital Management LLC14,302$41K0.0%N/A0.058%
11/17/2025 Millennium Management LLC262,160$752K0.0%-19.8%1.068%
11/17/2025 Citadel Advisors LLC798,397$2.29M0.0%+419.3%3.252%
11/17/2025Bank of America Corp DE16,145$46K0.0%+225.8%0.066%
11/13/2025 Landscape Capital Management L.L.C.39,133$112K0.0%N/A0.160%
11/13/2025 BNP Paribas Financial Markets118,547$340K0.0%+14,463.5%0.485%
8/15/2025 Bridgeway Capital Management LLC35,000$53K0.0%N/A0.143%
8/14/2025 Jane Street Group LLC44,215$67K0.0%N/A0.181%
8/14/2025 Qube Research & Technologies Ltd38,692$58K0.0%N/A0.158%
8/13/2025 Marshall Wace LLP52,213$79K0.0%N/A0.214%
8/8/2025 Geode Capital Management LLC159,041$240K0.0%-61.3%0.653%
8/1/2025 Y Intercept Hong Kong Ltd31,567$48K0.0%N/A0.130%
7/31/2025 Ground Swell Capital LLC24,849$38K0.1%N/A0.102%
5/15/2025venBio Partners LLC1,198,975$3.60M2.9%-21.1%4.921%
5/12/2025Nuveen LLC47,892$144K0.0%N/A0.197%
5/9/2025Charles Schwab Investment Management Inc.54,881$165K0.0%+26.1%0.225%
2/17/2025Deutsche Bank AG21,423$216K0.0%N/A0.088%
2/17/2025Bank of America Corp DE10,817$109K0.0%-39.3%0.045%
2/17/2025BNP Paribas Financial Markets9,879$100K0.0%+262.1%0.041%
2/14/2025Northern Trust Corp117,112$1.18M0.0%+3.8%0.482%
2/13/2025Barclays PLC24,161$244K0.0%+23.2%0.099%
2/13/2025Wells Fargo & Company MN8,616$87K0.0%+64.0%0.035%
2/12/2025Geode Capital Management LLC315,758$3.18M0.0%+2.2%1.300%
2/12/2025Norges Bank30,000$302K0.0%N/A0.124%
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)

Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel

Get the name and ticker of Louis Navellier's #1 AI stock free
2/12/2025JPMorgan Chase & Co.37,619$379K0.0%+250.7%0.155%
2/6/2025Charles Schwab Investment Management Inc.43,526$439K0.0%+8.0%0.179%
1/30/2025Rhumbline Advisers12,879$130K0.0%-13.1%0.053%
1/24/2025China Universal Asset Management Co. Ltd.5,150$52K0.0%N/A0.021%
12/26/2024JPMorgan Chase & Co.10,726$166K0.0%N/A0.044%
11/27/2024Franklin Resources Inc.520,301$7.44M0.0%N/A2.142%
11/19/2024Barclays PLC19,616$304K0.0%N/A0.081%
11/16/2024Geode Capital Management LLC308,930$4.77M0.0%N/A1.272%
11/15/2024Barclays PLC19,616$304K0.0%N/A0.081%
11/15/2024Wellington Management Group LLP194,108$2.91M0.0%N/A0.799%
11/15/2024State Street Corp86,559$1.34M0.0%N/A0.356%
11/15/2024Samsara BioCapital LLC291,666$4.51M0.9%N/A1.201%
11/15/2024RA Capital Management L.P.9,853,302$152.23M1.8%N/A40.565%
11/15/2024RTW Investments LP148,844$2.30M0.0%N/A0.613%
11/14/2024Acuta Capital Partners LLC44,000$680K0.6%N/A0.181%
11/14/2024MetLife Investment Management LLC8,733$135K0.0%N/A0.036%
11/13/2024BNP Paribas Financial Markets2,728$42K0.0%N/A0.011%
11/12/2024Charles Schwab Investment Management Inc.40,293$623K0.0%N/A0.166%


ARTV Institutional Ownership - Frequently Asked Questions

During the previous two years, 38 institutional investors and hedge funds held shares of Artiva Biotherapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($152.23M), Franklin Resources Inc. ($7.44M), Samsara BioCapital LLC ($4.51M), venBio Partners LLC ($3.42M), Wellington Management Group LLP ($2.91M), RTW Investments LP ($2.30M), and Citadel Advisors LLC ($2.29M).Learn more on Artiva Biotherapeutics' institutional investors.

Of the 34 institutional investors that purchased Artiva Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($9.85M), Citadel Advisors LLC ($644.66K), Franklin Resources Inc. ($520.30K), Geode Capital Management LLC ($315.76K), Samsara BioCapital LLC ($291.67K), Wellington Management Group LLP ($194.11K), and RTW Investments LP ($148.84K).

Institutional investors have bought a total of 1,297,116 shares in the last 24 months. This purchase volume represents approximately $3.90M in transactions.

The following institutional investors have sold Artiva Biotherapeutics stock in the last 24 months: venBio Partners LLC ($617.64K), Geode Capital Management LLC ($261.20K), Millennium Management LLC ($109.97K), Goldman Sachs Group Inc. ($37.72K), Renaissance Technologies LLC ($36.16K), State Street Corp ($24K), and Qube Research & Technologies Ltd ($13.14K).

Institutional investors have sold a total of 1,109,522 shares in the last 24 months. This volume of shares sold represents approximately $4.30M in transactions.


Related Companies

This page (NASDAQ:ARTV) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel